THE PROACT PHASE 3 STUDY DESIGN: A RANDOMIZED CONTROLLED STUDY OF REACT IN PARTICIPANTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE
Back
Abstract Number
WCN23-0424
Categories
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Diabetic Kidney Disease, Drugs and Treatments
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
THE PROACT PHASE 3 STUDY DESIGN: A RANDOMIZED CONTROLLED STUDY OF REACT IN PARTICIPANTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE
Co-authors
Cooper, K.(1)*;Lambers Heerspink, H.(2);Liew, A.(3);Stavas, J.(4);Mckenzie, L.(4);Bertram, T.(4);Johns, A.(4);Pecoits-Filho, R.(5);Tuttle, K.R.(6,7);
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)Prokidney, Clinical, Raleigh, United States;(2)University Medical Center Groningen, Clinical Pharmacy And Pharmacology, Groningen, Netherlands;(3)Mount Elizabeth Novena Hospital, Nephrology And Transplant, Singapore, Singapore;(4)Prokidney, N/A, Raleigh, United States;(5)University Of Michigan, School Of Medicine, Ann Arbor, United States;(6)University Of Washington, Nephrology, Seattle, United States;(7)Providence Research Center, N/A, Seattle, United States;
E-Poster
https://storage.unitedwebnetwork.com/files/1041/18b1d803d74a2743c0bf2044e23ff174.pdf
Audio File
if any